| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jerome Benedict Durso | CEO;Pres | 2026-08-13 | 15,000 | $2.95 | $44.25kBuy |
| M. Scot Roberts | CSci | 2026-07-31 | 875 | $2.41 | $2.11kBuy |
| Gregory L. Weaver | CFO | 2026-07-31 | 1,753 | $2.41 | $4.23kBuy |
| John Gill | Director | 2026-04-06 | 9,200 | $3.41 | $31.35kBuy |
| Gregory L. Weaver | Chief Financial Officer | 2026-04-01 | 10,000 | $3.15 | $31.50kBuy |
| Jerome Benedict Durso | President and CEO | 2026-04-01 | 15,000 | $3.14 | $47.10kBuy |
| Gregory L. Weaver | Chief Financial Officer | 2026-03-06 | 5,000 | $3.54 | $17.70kBuy |
| Jerome Benedict Durso | President and CEO | 2026-03-06 | 20,000 | $3.54 | $70.78kBuy |
| M. Scot Roberts | Chief Scientific Officer | 2026-02-02 | 2,329 | $5.55 | $12.93kSell |
| Raymond M. Jordt | Chief Business Officer | 2026-01-31 | 4,571 | $3.07 | $14.03kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Prescott Group Capital Management LLC | 10.20% | 19,837,273 | $58.92M | Insider |
| Novartis Bioventures Ltd | 4.29% | 8,345,145 | $24.79M | Insider |
| Mpm Bioventures III LLC | 3.26% | 6,347,614 | $18.85M | Insider |
| Luke Evnin | 3.26% | 6,347,614 | $18.85M | Insider |
| Healthcare Ventures VII LP | 2.25% | 4,378,057 | $13.00M | Insider |
| Venrock Healthcare Capital Partners III LP | 1.80% | 3,500,000 | $10.40M | Insider |
| James H. Cavanaugh | 1.71% | 3,317,243 | $9.85M | Insider |
| Velocity Pharmaceutical Holdings LLC | 0.87% | 1,687,250 | $5.01M | Insider |
| Derace L. Schaffer | 0.83% | 1,619,557 | $4.81M | Insider |
| Elizabeth Czerepak | 0.68% | 1,320,087 | $3.92M | Insider |